MetaCap

Penumbra (PEN) vs Solventum (SOLV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Penumbra (PEN) has outperformed Solventum (SOLV) over the past year, gaining 10.6% versus a gain of 1.9%. Solventum is the larger company by market cap ($14.36 billion vs $12.58 billion), about 1.1 times the size, while Penumbra is growing revenue faster (+17.5% vs +0.9%). On valuation, Solventum trades at a lower forward P/E (11.2x vs 53.1x for Penumbra).

Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 12.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PEN+10.63%SOLV+1.93%
+27%-0%-27%
Nov 21, 20251 yearNov 20, 2026
PEN+42.99%SOLV+21.50%
+65%+16%-34%
Mar 25, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PEN versus SOLV key metrics
MetricPENSOLV
Share price$319.12$84.50
Market cap$12.58B$14.36B
1-day change-0.28%-1.52%
YTD return+2.64%+6.64%
1-year return+10.63%+1.93%
5-year return+27.57%—
P/E ratio (TTM)80.3894.94
Forward P/E53.0911.20
EPS (TTM)$3.97$0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.40B$8.32B
Revenue growth (YoY)+17.50%+0.86%
Net income (latest FY)$177.69M$1.56B
Gross margin67.14%53.47%
Operating margin13.48%26.20%
Net margin12.66%18.69%
52-week high$362.41$94.16
52-week low$284.95$62.38
Distance from 52-week high-11.95%-10.26%
Analyst consensusholdbuy
Avg. price target upside+13.61%+16.43%
Average volume358.21K1.03M
Shares outstanding39.41M169.96M
Employees4,70020,584
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 12.7 cents for Penumbra.
  • Penumbra grew revenue faster in its latest fiscal year (+17.50% vs +0.86%).

About Penumbra

PEN stock →

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

Health Care · Medical/Dental Instruments · 4,700 employees

About Solventum

SOLV stock →

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.

Health Care · Medical/Dental Instruments · 20,584 employees

PEN vs SOLV FAQ

Which is bigger, Penumbra or Solventum?

Solventum (SOLV) is larger, with a market capitalization of $14.36B compared with $12.58B for Penumbra (PEN).

Which stock has performed better over the past year, PEN or SOLV?

PEN returned +10.63% over the past 12 months, compared with +1.93% for SOLV (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, PEN or SOLV?

PEN has the lower trailing P/E at 80.4, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Penumbra and Solventum in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons